Shares of Apollo Hospitals Enterprise Ltd surged five percent in trade on Wednesday, August 13, after the healthcare player posted its earnings show for the quarter ended June 30, 2025.
Apollo Hospitals reported a 42 percent year-on-year surge in consolidated net profit to Rs 433 crore for the quarter ended June 30, 2025, driven by robust performance across its core healthcare services, diagnostics, and digital health businesses.
Revenue rose 15 percent year-on-year to Rs 5,842 crore, while EBITDA grew 26 percent to Rs 852 crore, reflecting margin expansion and operational efficiencies.
At 9.20 a.m., shares were quoting Rs 7,591 on the NSE, up 4.9 percent.
Chairman Dr. Prathap C Reddy attributed the strong results to Apollo’s integrated care model and strategic investments in digital platforms and infrastructure. “Our three growth engines—Healthcare Services, Retail Health & Diagnostics, and Digital & Pharma Distribution—have all contributed meaningfully,” he said.
Looking ahead, Apollo plans to add over 4,300 beds over the next five years with an investment of Rs 7,600 crore, including expansions in Bengaluru and Hyderabad. The company also launched Apollo Zen, an AI-powered preventive health program, and OraLife for early oral cancer detection.
Hospital revenue rose 11 percent year-on-year, driven by a 3 percent increase in inpatient volumes and an 11 percent rise in ARPP, with margins improving by 89 basis points. Overall occupancy stood at 65 percent, down 300 basis points year-on-year. HealthCo revenues grew 19 percent, with margins up 41 basis points.
Nomura maintained its 'neutral' rating on Apollo Hospitals with a target price of Rs 6,856, noting in-line revenue and better-than-expected EBITDA.
Citi Research also maintained its 'buy' rating on Apollo Hospitals with a target price of Rs 8,260, highlighting strong Q1 performance and margin expansion in both HealthCo and Hospitals.
HealthCo posted solid growth, improved margins, and turned PAT positive, while the Hospitals segment also saw margin gains despite a drop in Bangladeshi patient inflows.
Follow our market blog to catch all the live updates
Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
